Unless the FDA is completely corrupt (a distinct possibility that I hope Q+ has remedied), Leronlimab by CytoDyn will be approved for the China Virus/Kung Flu in about 2 weeks. Then POOF the fear-mongering will no longer work - even for the brain-dead masses. Check out what CytoDyn's stock (CYDY:OTC) has been doing, $3 to $8 in the last 7 trading days.